[HTML][HTML] In search of a cure: the development of therapeutics to alter the progression of spinal muscular atrophy
KS Ojala, EJ Reedich, CJ DiDonato, SD Meriney - Brain Sciences, 2021 - mdpi.com
Until the recent development of disease-modifying therapeutics, spinal muscular atrophy
(SMA) was considered a devastating neuromuscular disease with a poor prognosis for most …
(SMA) was considered a devastating neuromuscular disease with a poor prognosis for most …
Emerging therapies and challenges in spinal muscular atrophy
Spinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity
ranging from progressive infantile paralysis and premature death (type I) to limited motor …
ranging from progressive infantile paralysis and premature death (type I) to limited motor …
[HTML][HTML] New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?
TH Chen - International journal of molecular sciences, 2020 - mdpi.com
Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
motor neuron loss, resulting in progressive weakness. SMA is notable in the health care …
Spinal muscular atrophy: a timely review
SJ Kolb, JT Kissel - Archives of neurology, 2011 - jamanetwork.com
Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by loss of
motor neurons in the anterior horn of the spinal cord and resultant weakness. The most …
motor neurons in the anterior horn of the spinal cord and resultant weakness. The most …
Spinal muscular atrophy
M Oskoui, P Kaufmann - Neurotherapeutics, 2008 - Springer
Spinal muscular atrophy (SMA) is a potentially devastating and lethal neuromuscular
disease frequently manifesting in infancy and childhood. The discovery of the underlying …
disease frequently manifesting in infancy and childhood. The discovery of the underlying …
Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next
Twenty-five years ago, the underlying genetic cause for one of the most common and
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …
devastating inherited diseases in humans, spinal muscular atrophy (SMA), was identified …
Treatment advances in spinal muscular atrophy
D Bharucha-Goebel, P Kaufmann - Current neurology and neuroscience …, 2017 - Springer
Abstract Purpose of Review Spinal muscular atrophy (SMA) is a genetic disorder of motor
neurons in the anterior horns of the spinal cord and brainstem that results in muscle atrophy …
neurons in the anterior horns of the spinal cord and brainstem that results in muscle atrophy …
Spinal muscular atrophy—insights and challenges in the treatment era
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease caused by
deletion or mutation of SMN1. Four subtypes exist, characterized by different clinical …
deletion or mutation of SMN1. Four subtypes exist, characterized by different clinical …
Therapeutic approaches for spinal muscular atrophy (SMA)
Spinal muscular atrophy is an autosomal recessive neurodegenerative disorder
characterized by progressive muscle wasting and loss of muscle function due to severe …
characterized by progressive muscle wasting and loss of muscle function due to severe …
Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities
Introduction Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative
neuromuscular disease that presents primarily in children. Abnormalities in the SMN1 gene …
neuromuscular disease that presents primarily in children. Abnormalities in the SMN1 gene …